Lexeo Therapeutics, Inc. Common Stock
LXEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $35 | $121 | $77 | $136 |
| Short-Term Investments | $87 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $3 | $3 | $1 |
| Total Curr. Assets | $126 | $124 | $80 | $137 |
| Property Plant & Equip (Net) | $11 | $12 | $14 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $7 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $3 | $7 | $0 |
| Total NC Assets | $21 | $16 | $21 | $0 |
| Other Assets | $0 | $0 | -$4 | $0 |
| Total Assets | $147 | $140 | $97 | $137 |
| Liabilities | – | – | – | – |
| Payables | $6 | $4 | $3 | $3 |
| Short-Term Debt | $3 | $3 | $3 | $0 |
| Tax Payable | $0 | $0 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $11 | $8 | $4 |
| Total Curr. Liab. | $23 | $17 | $14 | $7 |
| LT Debt | $7 | $9 | $11 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $185 | $185 |
| Total NC Liab. | $7 | $9 | $196 | $185 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $12 | $13 | $0 |
| Total Liabilities | $30 | $26 | $210 | $192 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $185 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$280 | -$182 | -$115 | -$56 |
| AOCI | -$0 | $0 | -$185 | -$185 |
| Other Equity | $397 | $295 | $188 | $1 |
| Total Equity | $117 | $114 | -$113 | -$56 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $147 | $140 | $97 | $137 |
| Net Debt | -$25 | -$110 | -$64 | -$136 |